DE68923123T2 - Herstellung von Proteinen. - Google Patents

Herstellung von Proteinen.

Info

Publication number
DE68923123T2
DE68923123T2 DE68923123T DE68923123T DE68923123T2 DE 68923123 T2 DE68923123 T2 DE 68923123T2 DE 68923123 T DE68923123 T DE 68923123T DE 68923123 T DE68923123 T DE 68923123T DE 68923123 T2 DE68923123 T2 DE 68923123T2
Authority
DE
Germany
Prior art keywords
production
proteins
yeast strains
transformed
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68923123T
Other languages
English (en)
Other versions
DE68923123D1 (de
Inventor
Hansjoerg Dr Treichler
Kenji Dr Takabayashi
Dieter Heinrich Prof Dr Wolf
Jutta Dr Heim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Ag Basel Ch Ucp Gen-Pharma Ag Zuerich
Original Assignee
UCP GEN-PHARMA AG ZUERICH CH
Ciba Geigy AG
UCP Gen Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888810524A external-priority patent/GB8810524D0/en
Priority claimed from GB888812627A external-priority patent/GB8812627D0/en
Priority claimed from GB898907110A external-priority patent/GB8907110D0/en
Application filed by UCP GEN-PHARMA AG ZUERICH CH, Ciba Geigy AG, UCP Gen Pharma AG filed Critical UCP GEN-PHARMA AG ZUERICH CH
Publication of DE68923123D1 publication Critical patent/DE68923123D1/de
Application granted granted Critical
Publication of DE68923123T2 publication Critical patent/DE68923123T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
DE68923123T 1988-05-04 1989-05-01 Herstellung von Proteinen. Expired - Lifetime DE68923123T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888810524A GB8810524D0 (en) 1988-05-04 1988-05-04 Improvements in production of polypeptides
GB888812627A GB8812627D0 (en) 1988-05-27 1988-05-27 Improvements in production of polypeptides
GB898907110A GB8907110D0 (en) 1988-05-04 1989-03-29 Improvements in the production of polypeptides

Publications (2)

Publication Number Publication Date
DE68923123D1 DE68923123D1 (de) 1995-07-27
DE68923123T2 true DE68923123T2 (de) 1995-11-30

Family

ID=27263890

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68923123T Expired - Lifetime DE68923123T2 (de) 1988-05-04 1989-05-01 Herstellung von Proteinen.

Country Status (16)

Country Link
EP (1) EP0341215B1 (de)
JP (1) JPH0824565B2 (de)
AT (1) ATE124086T1 (de)
AU (1) AU614121B2 (de)
CA (1) CA1340016C (de)
DE (1) DE68923123T2 (de)
DK (1) DK175701B1 (de)
ES (1) ES2072918T3 (de)
FI (1) FI103129B1 (de)
HU (1) HU218731B (de)
IE (1) IE66044B1 (de)
IL (1) IL90170A (de)
MX (1) MX169508B (de)
NO (1) NO180593C (de)
NZ (1) NZ228955A (de)
PT (1) PT90436B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8809860D0 (en) * 1988-04-26 1988-06-02 Ciba Geigy Ag Process for production of polypeptides
FR2645175B1 (fr) * 1989-03-31 1994-02-18 Transgene Sa Souche de saccharomyces cerevisiaeproductrice d'une proteine heterologue et procede de preparation de ladite proteine heterologue par fermentation de ladite souche
FR2645174B1 (fr) * 1989-03-31 1994-01-07 Transgene Sa Souches de levure ameliorees pour la production de proteines heterologues matures en particulier d'hirudine et procede de preparation d'hirudine correspondant
US5879926A (en) * 1989-03-31 1999-03-09 Transgene S.A. Yeast strains for the production of mature heterologous proteins, especially hirudin
EP0502962B1 (de) * 1989-12-01 1996-03-13 BASF Aktiengesellschaft Hirudin-Muteine und deren Polyalkylenglykolkonjugate
DE69114500T2 (de) * 1990-07-13 1996-06-13 Transkaryotic Therapies Inc Verfahren zum absuchen einer bibliothek.
US5580734A (en) * 1990-07-13 1996-12-03 Transkaryotic Therapies, Inc. Method of producing a physical map contigous DNA sequences
US5612198A (en) * 1990-09-04 1997-03-18 The Salk Institute Production of insulin-like growth factor-1 in methylotrophic yeast cells
CA2090969C (en) * 1990-09-04 2001-08-21 Russell Arthur Brierley Production of insulin-like growth factor-1 in methylotrophic yeast cells
CA2072375C (en) 1990-11-08 2000-01-11 Satoru Misawa Hirudin analog, method of manufacturing thereof and anti-coagulant composition, and secretion vector, transformed microorganisms containing saidvector and manufacturing method of products which is produced from said microorganism
SG84484A1 (en) * 1991-02-25 2001-11-20 Ciba Geigy Ag Improved yeast vectors
ATE220105T1 (de) * 1991-04-01 2002-07-15 Merck & Co Inc Gene, die die proteolytische aktivitaet von pichia beeinflussen und deren verwendung
HU214698B (hu) * 1992-04-09 1998-06-29 Gyógyszerkutató Intézet Kft. Eljárás rekombináns deszulfátó-hirudin HV-1 peptidek előállítására
DE69329540T2 (de) * 1992-09-04 2001-06-07 Novartis Ag Verfahren zur Herstellung von Proteaseinhibitoren
TW282490B (de) * 1992-12-15 1996-08-01 Ciba Geigy Ag
AU685835B2 (en) * 1993-08-04 1998-01-29 Novartis Ag High molecular weight desulphatohirudin
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
JP3732516B2 (ja) * 1995-02-09 2006-01-05 ノバルティス・アクチエンゲゼルシャフト タンパク質の製造法
US5861280A (en) * 1995-03-20 1999-01-19 Novo Nordisk A/S Host cell expressing reduced levels of a metalloprotease and methods using the host cell in protein production
DE19529997C1 (de) 1995-08-16 1997-04-10 Hoechst Ag Verfahren zur Inaktivierung von Carboxypeptidase Y in hirudinhaltigen Kulturbrühen
AU7112796A (en) * 1995-09-27 1997-04-17 Chiron Corporation Method of making a protease deficient host
DE69624087T2 (de) 1996-01-31 2003-06-05 Sumitomo Bakelite Co Verfahren zur Herstellung von in Epoxyharz eingekapselter Halbleitervorrichtung
FR2768743B1 (fr) * 1997-09-23 2001-09-14 Bio Merieux Procede de lyse de micro-organisme
GB2338236B (en) 1998-06-13 2003-04-09 Aea Technology Plc Microbiological cell processing
US7795205B2 (en) 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
CN102639559B (zh) 2009-11-25 2015-04-29 诺沃—诺迪斯克有限公司 用于制备多肽的方法
KR102620914B1 (ko) 2017-10-10 2024-01-05 아지노모토 가부시키가이샤 단백질의 제조 방법
CN115836127A (zh) 2020-06-11 2023-03-21 味之素株式会社 蛋白的制造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
JPS62224284A (ja) * 1986-03-25 1987-10-02 Agency Of Ind Science & Technol 微生物
GB8809860D0 (en) * 1988-04-26 1988-06-02 Ciba Geigy Ag Process for production of polypeptides
GB8817160D0 (en) * 1988-07-19 1988-08-24 Ciba Geigy Ag Novel proteins
GB8817161D0 (en) * 1988-07-19 1988-08-24 Ciba Geigy Ag Modified proteins

Also Published As

Publication number Publication date
AU3382889A (en) 1989-11-09
EP0341215B1 (de) 1995-06-21
DE68923123D1 (de) 1995-07-27
PT90436B (pt) 1994-11-30
NO180593B (no) 1997-02-03
AU614121B2 (en) 1991-08-22
EP0341215A3 (de) 1992-01-15
JPH02104279A (ja) 1990-04-17
ATE124086T1 (de) 1995-07-15
IL90170A (en) 1995-12-31
FI103129B (fi) 1999-04-30
EP0341215A2 (de) 1989-11-08
HU218731B (hu) 2000-11-28
DK217589D0 (da) 1989-05-03
FI892114A (fi) 1989-11-05
DK175701B1 (da) 2005-01-24
ES2072918T3 (es) 1995-08-01
NO891837L (no) 1989-11-06
IE66044B1 (en) 1995-12-13
NO180593C (no) 1997-05-14
PT90436A (pt) 1989-11-30
DK217589A (da) 1989-11-05
FI103129B1 (fi) 1999-04-30
CA1340016C (en) 1998-08-25
IE891451L (en) 1989-11-04
NZ228955A (en) 1991-06-25
HUT54210A (en) 1991-01-28
NO891837D0 (no) 1989-05-03
IL90170A0 (en) 1989-12-15
MX169508B (es) 1993-07-08
FI892114A0 (fi) 1989-05-03
JPH0824565B2 (ja) 1996-03-13

Similar Documents

Publication Publication Date Title
ATE124086T1 (de) Herstellung von proteinen.
ATE112802T1 (de) Herstellung von funktionellen menschlichen urokinasepolypeptiden.
ES2061682T3 (es) Cisteina proteinasas, produccion y uso.
DE3853023T2 (de) Produktion von Kallikrein.
ATE71658T1 (de) Verfahren zur herstellung von humanlysozym.
FI931634A0 (fi) Nytt svampproteas
NO944181D0 (no) Proteaser for sopp
EP0307472A4 (de) Immunogenes produkt, erhalten durch expression in einer rekombinanten hefe, und verfahren zu seiner reinigung.
AU591305B2 (en) Improved process for preparing 5,6-substitued-2,4- quinazolinediamines and novel intermediates
DE69329540D1 (de) Verfahren zur Herstellung von Proteaseinhibitoren
DE68908843T2 (de) Verfahren zur Herstellung von 4,6-Dimethyl-7-hydroxynonan-3-on.
GR3007115T3 (de)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NOVARTIS AG, BASEL, CH UCP GEN-PHARMA AG, ZUERICH,

8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN